Analyst Ratings for Supernus Pharmaceuticals Inc. (SUPN)

Updated: 2017-07-27

An average rating of Overweight has been given to Supernus Pharmaceuticals Inc. (NASDAQ:SUPN) by analysts covering the stock. SUPN had previously received a consensus rating of Buy a month ago.

Of the 7 analysts covering the stock, 5 gave it a buy rating, 0 issued an overweight rating, 2 issued a hold rating, 0 gave an underweight rating, and 0 issued a sell rating. Over the past 90 days, the number of analysts that are bullish on the stock has increased by 0. During this time, the number of analysts bearish on the stock has increased by 0.

Several price targets were given for SUPN by the analysts covering the stock. The maximum price target given was 51, which equates to a potential upside of 24.09 percent. The lowest price target was 40, implying potential capital losses of -2.68 percent. Some investors take price targets and stock ratings with a grain of salt, knowing that some analysts can have indirect business with the stocks they cover.

Analysts have revised their earnings estimates downwards for this quarter, by about -7.56 percent on average, compared to last month. The average change in earnings estimates over the last 90 days is -23.79 percent. On the other hand, earnings estimates for the fiscal year have been revised downwards by -7.71 percent, as compared to a month ago. If we look at the last 90 days instead, we find a net average change of -21.32 percent in FY estimates.

Another thing investors often look at is the level of agreement among analysts' revisions. 0 analysts have revised their quarterly estimates upwards in the past 30 days, while 3 analysts revised their estimates downwards. Over the same time period, 0 analysts revised their FY earnings estimates upwards, compared to 3 analysts that revised their FY estimates downwards.

The growth rate of SUPN's earnings is estimated by analysts to be -46.43 percent. Another measure frequently examined by investors is the PEG ratio. Investors like to see smaller values for the PEG ratio, as that can indicate whether the high price level of a stock is warranted by high growth. Many investors consider PEG ratios between 0 and 1 as preferrable, even though it may be more relevant to compare the ratio to that of a firm's competitors. The PEG ratio of SUPN is -0.48.

In the trailing 52-weeks, SUPN hit 44.95 at the highest peak, while it's lowest trading point was 17.25. The current market price is above the trailing year's low by 138.26 percent, and 8.57 percent lower than its 52-week high. SUPN has a price/earnings ratio of 22.48. Investors typically compare the P/E ratio to a company's peers in the industry. The SUPN value stock report compares SUPN to some of its peers using value stock charts. The stock has a market capitalization of $2.12 billion. SUPN's next earnings release will be on 0000-00-00, which is days away.